It should be also mentioned that, although IL-6 is one of the main cytokines involved in COVID-19 inflammatory response, clinical trials with IL-6 receptor antagonists gave conflicting outcomes, and the effectiveness of IL-6 targeting approach remains to be established (56, 57). This evidence concerns the gene IL6 and COVID-19.